These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 35281015)

  • 21. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.
    Khashkhashi Moghadam S; Bakhshinejad B; Khalafizadeh A; Mahmud Hussen B; Babashah S
    J Cell Mol Med; 2022 Jan; 26(2):287-305. PubMed ID: 34907642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
    Ferro A; Saccu G; Mattivi S; Gaido A; Herrera Sanchez MB; Haque S; Silengo L; Altruda F; Durazzo M; Fagoonee S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characteristics of novel immune subtypes of HCC based on lncRNAs related to immune disorders.
    Zhang Q; Yu X; Zhang S; Guo W; He Y
    Sci Rep; 2022 May; 12(1):8905. PubMed ID: 35618810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
    Xu K; Xia P; Chen X; Ma W; Yuan Y
    Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
    Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
    Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of noncoding RNAs in septic acute kidney injury.
    Yue L; Gu Y; Xu J; Liu T
    Biomed Pharmacother; 2023 Sep; 165():115269. PubMed ID: 37541179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
    Feng Q; Zhang H; Yao D; Chen WD; Wang YD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-coding RNA dysregulation in skin cancers.
    Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
    Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Shi T; Morishita A; Kobara H; Masaki T
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncoding RNAs in cancer and cancer stem cells.
    Huang T; Alvarez A; Hu B; Cheng SY
    Chin J Cancer; 2013 Nov; 32(11):582-93. PubMed ID: 24206916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma.
    Huang Q; Zhong X; Li J; Hu R; Yi J; Sun J; Xu Y; Zhou X
    Biomed Pharmacother; 2024 Apr; 173():116409. PubMed ID: 38460375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research progress of non-coding RNA-encoding polypeptides in primary hepatocellular carcinoma].
    Chen DM; Yu Z; Zhang ZW; Huang JL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):91-96. PubMed ID: 38320799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
    Lv H; Lv G; Han Q; Yang W; Wang H
    Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma.
    Pea A; Jamieson NB; Braconi C
    Hepatology; 2021 Jan; 73 Suppl 1():38-48. PubMed ID: 32160335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
    Jia Z; Jia J; Yao L; Li Z
    Front Immunol; 2022; 13():900155. PubMed ID: 35663957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.